CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the Age of COVID-19” series co-hosted by CAACB and BioMAN. The summary presents a snapshot of information drawn from expert presentations and a pre-workshop survey of consortia members, covering topics such as prevention of process and product contamination with SARS-CoV-2, business continuity, and the impact on ATMPs.
Read the full article HERE.
